S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7233 −0.26%
CLOSED · 16:55 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead
AC
INSIDER · TENX · TENAX THERAPEUTICS, INC. · 10% OWNER

ADAR1 Capital Management, LLC

Every open-market transaction filed under this name, Aug 20 to Sep 2.

Filings
6
6 buys · 0 sells
Bought
$3.2M
open market, at cost
Sold
includes scheduled sales
Buys since
+8.9%
avg move from buy price, 6 priced

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 2TENXTENAX THERAPEUTICS, INC.10% ownerBuy187,704$1.80$338K+7.9%
Sep 1TENXTENAX THERAPEUTICS, INC.10% ownerBuy179,058$1.80$322K+8.0%
Aug 31TENXTENAX THERAPEUTICS, INC.10% ownerBuy403,571$1.79$723K+8.3%
Aug 24TENXTENAX THERAPEUTICS, INC.10% ownerBuy107,374$1.75$188K+10.6%
Aug 21TENXTENAX THERAPEUTICS, INC.10% ownerBuy716,369$1.77$1.3M+9.8%
Aug 20TENXTENAX THERAPEUTICS, INC.10% ownerBuy202,124$1.78$360K+9.1%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.